The test of pandemic preparedness
Published: 04:10 PM,Oct 31,2021 | EDITED : 08:10 PM,Oct 31,2021
The Covid-19 pandemic has instilled many harsh lessons. But the most important is that infectious-disease outbreaks pose a risk not just to public health but also to global security. Like nuclear proliferation, terrorism, and climate change, Covid-19 has shown that pandemics can rapidly undermine social stability and economic well-being.
This point may seem obvious now. But before the Covid-19 crisis, infectious disease barely registered on the global security agenda. If efforts to change that by establishing new funding and monitoring mechanisms for pandemic preparedness are to succeed, half measures won’t cut it. To avoid a repeat of history, our preparations must reflect the true extent of the challenge. We must recognise that pandemics now represent one of the biggest — and most likely — threats to global security.
Preventing future pandemics will require not only the same level of investment as other global security threats, on which trillions are spent routinely, but also an entirely different way of thinking about global security. The pandemic represents a new form of globalised crisis, one that is both caused and exacerbated by the modern world’s interconnectedness.
The Spanish influenza pandemic a century ago was not this kind of crisis. Back then, most people across the globe lived in less dense rural settings, and international travel was much slower and undertaken by only a small fraction of the population. But we saw something similar in 2008-09, when economies fell like dominoes. That was the first globalised crisis of this century, and we are now coming to grips with what will be the century’s defining crisis: climate change.
The common denominator in each case is that the crisis demands solutions that no individual government can provide on its own. An infectious disease cannot be fought with traditional security countermeasures such as economic sanctions, bilateral diplomacy, deterrence, or military posturing. Rather, it calls for scientific collaboration, resilient health systems, and long-term investments in global health networks. Shows of force and unilateral acts of national self-preservation are useless. Global collaboration, strategic multilateralism, and transnational compassion are the only way out of this kind of disaster.
Judging by the current global distribution of Covid-19 vaccines, we have yet to muster the necessary response. The coronavirus is still winning, and a lack of global coordination is the principal reason why. Instead of finding ways to work together towards common solutions in the face of an unprecedented crisis, key governments are still putting their national interest first, at the expense of the global response we need.
The global solution to the vaccine distribution problem is the Covid-19 Vaccine Global Access (COVAX) facility established last year. By ensuring equitable access to vaccines for people in the poorest countries, Covax is not only saving millions of lives and protecting hundreds of millions more; it is also offering the best path to recovery. Even from a strictly economic standpoint, Covax is far more cost-effective than any form of fiscal or monetary stimulus.
There are now more than 1.5 billion vaccine doses being produced each month — an astounding feat less than a year after the first vaccine was approved, and just 18 months into the pandemic. It is predicted that a total of more than 12 billion doses will have been produced by the end of this year.
Copyright: Project Syndicate 2021
This point may seem obvious now. But before the Covid-19 crisis, infectious disease barely registered on the global security agenda. If efforts to change that by establishing new funding and monitoring mechanisms for pandemic preparedness are to succeed, half measures won’t cut it. To avoid a repeat of history, our preparations must reflect the true extent of the challenge. We must recognise that pandemics now represent one of the biggest — and most likely — threats to global security.
Preventing future pandemics will require not only the same level of investment as other global security threats, on which trillions are spent routinely, but also an entirely different way of thinking about global security. The pandemic represents a new form of globalised crisis, one that is both caused and exacerbated by the modern world’s interconnectedness.
The Spanish influenza pandemic a century ago was not this kind of crisis. Back then, most people across the globe lived in less dense rural settings, and international travel was much slower and undertaken by only a small fraction of the population. But we saw something similar in 2008-09, when economies fell like dominoes. That was the first globalised crisis of this century, and we are now coming to grips with what will be the century’s defining crisis: climate change.
The common denominator in each case is that the crisis demands solutions that no individual government can provide on its own. An infectious disease cannot be fought with traditional security countermeasures such as economic sanctions, bilateral diplomacy, deterrence, or military posturing. Rather, it calls for scientific collaboration, resilient health systems, and long-term investments in global health networks. Shows of force and unilateral acts of national self-preservation are useless. Global collaboration, strategic multilateralism, and transnational compassion are the only way out of this kind of disaster.
Judging by the current global distribution of Covid-19 vaccines, we have yet to muster the necessary response. The coronavirus is still winning, and a lack of global coordination is the principal reason why. Instead of finding ways to work together towards common solutions in the face of an unprecedented crisis, key governments are still putting their national interest first, at the expense of the global response we need.
The global solution to the vaccine distribution problem is the Covid-19 Vaccine Global Access (COVAX) facility established last year. By ensuring equitable access to vaccines for people in the poorest countries, Covax is not only saving millions of lives and protecting hundreds of millions more; it is also offering the best path to recovery. Even from a strictly economic standpoint, Covax is far more cost-effective than any form of fiscal or monetary stimulus.
There are now more than 1.5 billion vaccine doses being produced each month — an astounding feat less than a year after the first vaccine was approved, and just 18 months into the pandemic. It is predicted that a total of more than 12 billion doses will have been produced by the end of this year.
Copyright: Project Syndicate 2021